Search Results - "Helfrich, BA"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines by Weiss, G.J., Bemis, L.T., Nakajima, E., Sugita, M., Birks, D.K., Robinson, W.A., Varella-Garcia, M., Bunn, P.A., Haney, J., Helfrich, B.A., Kato, H., Hirsch, F.R., Franklin, W.A.

    Published in Annals of oncology (01-06-2008)
    “…Allelic loss in chromosome 3p is one of the most frequent and earliest genetic events in lung carcinogenesis. We investigated if the loss of microRNA-128b, a…”
    Get full text
    Journal Article
  2. 2

    A High-Yielding Supramolecular Reaction by Aakeröy, Christer B, Beatty, Alicia M, Helfrich, Brian A

    Published in Journal of the American Chemical Society (04-12-2002)
    “…The X-ray crystal structure determinations of twelve cocrystals involving iso-nicotinamide and a variety of carboxylic acids have revealed a very consistent…”
    Get full text
    Journal Article
  3. 3

    "Total Synthesis" Supramolecular Style: Design and Hydrogen-Bond-Directed Assembly of Ternary Supermolecules by Aakeröy, Christer B., Beatty, Alicia M., Helfrich, Brian A.

    Published in Angewandte Chemie International Edition (03-09-2001)
    “…Getting the right balance between intermolecular interactions is crucial for the synthesis of supermolecules in a preconceived manner. The three‐component…”
    Get full text
    Journal Article
  4. 4

    Do Polymorphic Compounds Make Good Cocrystallizing Agents? A Structural Case Study that Demonstrates the Importance of Synthon Flexibility by Aakeröy, Christer B, Beatty, Alicia M, Helfrich, Brian A, Nieuwenhuyzen, Mark

    Published in Crystal growth & design (01-03-2003)
    “…The ability of four polymorphic compounds, isonicotinamide (1), 2-amino-3-nitropyridine (2), 4-chlorobenzamide (3), and maleic hydrazide (4), to form molecular…”
    Get full text
    Journal Article
  5. 5

    Epidermal growth factor receptor family in lung cancer and premalignancy by Franklin, Wilbur A, Veve, Robert, Hirsch, Fred R, Helfrich, Barbara A, Bunn, Paul A

    Published in Seminars in oncology (01-02-2002)
    “…Lung cancer, like many other epithelial malignancies, is thought to be the outcome of genetic and epigenetic changes that result in a constellation of…”
    Get full text
    Journal Article
  6. 6

    PTTG1 Levels Are Predictive of Saracatinib Sensitivity in Ovarian Cancer Cell Lines by Nakachi, I, Helfrich, BA, Spillman, MA, Mickler, EA, Olson, CJ, Rice, JL, Coldren, CD, Heasley, LE, Geraci, MW, Stearman, RS

    Published in Clinical and translational science (01-12-2016)
    “…Src kinase is recognized as a key target for molecular cancer therapy. However, methods to efficiently select patients responsive to Src inhibitors are…”
    Get full text
    Journal Article
  7. 7

    ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non–small cell lung cancer by Raben, David, Helfrich, Barbara A., Chan, Dan, Johnson, Gary, Bunn, Paul A.

    Published in Seminars in oncology (01-02-2002)
    “…The epidermal growth factor receptor is overexpressed in a majority of non–small cell lung cancers and has been associated with a poor prognosis. Preclinical…”
    Get full text
    Journal Article
  8. 8

    Metal-Containing Dicarboxylic Acids as Building Blocks for Lamellar Inorganic−Organic Hybrid Networks by Beatty, Alicia M, Helfrich, Brian A, Hogan, Greg A, Reed, Beth Ann

    Published in Crystal growth & design (01-01-2006)
    “…The synthesis of two transition-metal-containing dicarboxylic acids, and their use as starting materials in the supramolecular synthesis of eight different…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Intramolecular Hydrogen Bonding and Intermolecular Dimerization in the Crystal Structures of Imidazole-4,5-dicarboxylic Acid Derivatives by Baures, Paul W, Rush, Jeremy R, Wiznycia, Alexander V, Desper, John, Helfrich, Brian A, Beatty, Alicia M

    Published in Crystal growth & design (01-11-2002)
    “…Diamide and amide-ester derivatives of imidazole-4,5-dicarboxylic acid form reliable hydrogen-bonding motifs in the solid state. The crystal structures of…”
    Get full text
    Journal Article
  11. 11

    Effects of recombinant neutral endopeptidase (EC 3.4.24.11) on the growth of lung cancer cell lines in vitro and in vivo by P A Bunn, Jr, B A Helfrich, D G Brenner, D C Chan, D J Dykes, A J Cohen, Y E Miller

    Published in Clinical cancer research (01-11-1998)
    “…Many lung cancers are stimulated by an autocrine/paracrine system of neuroendocrine peptide hormones. Attempts to block this autocrine growth pathway by…”
    Get full text
    Journal Article
  12. 12

    Induction of human lymphokine-activated killer cells by IFN-alpha and IFN-gamma by Ellis, TM, McKenzie, RS, Simms, PE, Helfrich, BA, Fisher, RI

    Published in The Journal of immunology (1950) (15-12-1989)
    “…By traditional definitions, NK cells can be activated by cytokines to exhibit two functionally distinct levels of cytotoxicity. Whereas IL-2-mediated…”
    Get full text
    Journal Article
  13. 13

    Identification of a novel CD56 super(-) lymphokine-activated killer cell precursor in cancer patients receiving recombinant interleukin 2 by McKenzie, R S, Simms, P E, Helfrich, BA, Fisher, R I, Ellis, T M

    Published in Cancer research (Chicago, Ill.) (01-01-1992)
    “…Circulating lymphokine-activated killer (LAK) cell activity in cancer patients receiving recombinant interleukin 2 (rIL-2) therapy is confined to cells…”
    Get full text
    Journal Article
  14. 14

    Identification of a novel CD56- lymphokine-activated killer cell precursor in cancer patients receiving recombinant interleukin 2 by MCKENZIE, R. S, SIMMS, P. E, HELFRICH, B. A, FISHER, R. I, ELLIS, T. M

    Published in Cancer research (Chicago, Ill.) (15-11-1992)
    “…Circulating lymphokine-activated killer (LAK) cell activity in cancer patients receiving recombinant interleukin 2 (rIL-2) therapy is confined to cells…”
    Get full text
    Journal Article
  15. 15

    Age-related changes in the degeneracy of the mouse T-cell repertoire by Helfrich, B A, Segre, M, Segre, D

    Published in Cellular immunology (01-01-1989)
    “…Aging is associated with a decline in T-cell-dependent immune responses. As the number of T-cells remains relatively constant throughout life, the observed…”
    Get more information
    Journal Article